Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#1840
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.79%
Monthly Change
+11.53%
6 month change
+56.39%
Year Change
+56.39%
Previous Close
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Volume
74
Markets
US Stock Market
Healthcare
ANAB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
FDA accepts Vanda’s imsidolimab application for rare skin disorder
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation
Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock
Anaptysbio CEO Faga sells $638k in shares
Anaptysbio CFO Mulroy sells $112k in shares
Anaptysbio (ANAB) chief medical officer sells $163,191 in stock
Anaptysbio CLO Loumeau sells $98,809 in shares